About Bioscience
Bioscience is a company based in Allentown (United States) founded in 1984. Bioscience has raised $17 million across 2 funding rounds from investors including Perceptive Advisors and Xontogeny. Bioscience offers products and services including MICROCAT Products, Ampulmatic-10, and accu-TEST COD Testing Kit. Bioscience operates in a competitive market with competitors including Pentair, ACCIONA, GSK, Avidity Biosciences and Sutro Biopharma, among others.
- Headquarter Allentown, United States
- SectorsHealthcareEnvironment
- Email••••••••
- Phone•••• ••••
- Website bioscienceinc.com
- Social LinkedIn X Facebook
- Legal Name Monera Technologies Corporation
- Total Equity Funding$17M (USD)
in 2 rounds
- Latest Funding Round$17M (USD), Series A
Dec 2019
- InvestorsPerceptive Advisors
& 1 more
Products & Services of Bioscience
Bioscience offers a comprehensive portfolio of products and services, including MICROCAT Products, Ampulmatic-10, and accu-TEST COD Testing Kit.
Enhances biological activity for wastewater treatment in various applications
Fills and seals ampules for microbial product preparation
Measures chemical oxygen demand in wastewater samples
Funding Insights of Bioscience
Bioscience has successfully raised a total of $17M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17M
- Total Rounds 2
- Last Round Series A — $17M
- Investors Count 2
All 2 funding rounds of Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | $17M | Series A | – | Perceptive Advisors | – |
| Jun 2017 | – | Unspecified | – | Xontogeny | – |
2 investors in total: 2 institutional.
Investors in Bioscience
Bioscience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Perceptive Advisors and Xontogeny.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Life science startups are accelerated through focused programs by Xontogeny. | 2016 | xontogeny.com | Boston, United States |
Investor details for Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bioscience
3 dated milestones of Bioscience across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Bioscience is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $17.0M.
Competitors of Bioscience
Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pentair, ACCIONA, GSK, Avidity Biosciences and Sutro Biopharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pentair.com | 1966 | London, United Kingdom | – | 558 | Water and waste treatment services are provided worldwide. | |
| acciona.com | 1931 | Alcobendas, Spain | – | 51 | Sustainable infrastructure solutions in renewable energy are developed and managed. | |
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| alfalaval.com | 1883 | Lund, Sweden | – | – | Water treatment, food processing, and pharmaceutical services are provided. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioscience
Websites that share an audience with Bioscience (bioscienceinc.com).
Websites whose visitors overlap most with Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
custombio.com | custombio.com | 100% | – | – | – |
microbial-products.com | microbial-products.com | 100% | – | – | – |
n-con.com | n-con.com | 99% | – | – | – |
bionutratech.com | bionutratech.com | 99% | – | – | – |
bestechcorp.com | bestechcorp.com | 99% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Bioscience
Complete news archive for Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Bioscience
10 companies that operate in the same segment as Bioscience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioscience
Bioscience was founded in 1984 and raised its 1st funding round 33 years after it was founded.
Bioscience is headquartered in Allentown, United States. It is registered at Allentown, Pennsylvania, United States.
Bioscience is a funded company, having raised a total of $17M across 2 funding rounds to date.
Bioscience, Inc. was founded in 1984 and is headquartered in Allentown, United States. Operations are centered in industrial microbiology, where microbial products and solutions are developed for biological wastewater treatment. Analytical products and test kits are manufactured for wastewater analysis. The MICROCAT brand is applied in bioaugmentation, process improvement, and stabilization across municipal, industrial, commercial, aquacultural, agricultural, and residential sectors.
Bioscience's top competitors include ACCIONA, Sutro Biopharma and Pentair.
Bioscience offers MICROCAT Products, Ampulmatic-10, and accu-TEST COD Testing Kit.
Bioscience has 2 investors. Key investors include Perceptive Advisors, and Xontogeny.
Bioscience operates through Monera Technologies Corporation.